Pharmaceutical company outsource the various processes of Pharmacovigilance to a service provider to carry out the business process. For every active partner, the PVA Agreement also called as Safety Data Exchange Agreement becomes a mandate. The various phases of establishing the executive agreement is an extended process involving multiple stakeholders resulting in the scattered information passed through various channels.
In recent years with the increasing number of programs has increased the number of active PVA agreements. The PVA office and PV QA team are in turmoil with source truth and maintenance of the PV Agreements. The PV team do not have oversight over the partner performance on various aspects.
How Do we Deliver
Compier Agreements (SDEA) module is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform. Our technology platform and subject matter expertise enable you with a comprehensive solution to digitalize the PV Agreement (SDEA) and track the Vendor performance on Timelines and Quality ensuring process and performance optimization
New Insights
Food & Nutraceuticals: How Companies can Prove Health Value with Clinical Trials
What are Food and Nutraceuticals? ‘Nutraceuticals’ is a composite term of ‘nutrition’ and ‘pharmaceutical’. They are a blend of products that possess both nutritional as well as medicinal value. They are designed to improve physical health, boost immunity, and deal with stress and increase longevity. Nutraceutical products play a significant role in maintaining normal physiological [...]
Best Practices for Signal Management in Pharmacovigilance
Pharmacovigilance involves the collection, detection, assessment, and monitoring of data on Adverse Drug Reactions (ADRs) which must be evaluated to derive vital safety information. Signal detection involves monitoring the adverse reaction data for patterns that suggest new safety information. Safety signals can be detected from an extensive range of sources, such as spontaneous reports, clinical [...]
Enabling eSource in Clinical Studies to Optimize Trial Quality
Source data is all information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. The electronic data source or eSource is the data that is initially recorded in electronic format in this process. Biopharma and [...]